The authors showed that the knockout of ATOX decreased ERK1/2 phosphorylation and reduced cell growth in A375 and WM888 melanoma cell lines harboring the oncogenic mutations in the Ser/Thr kinase BRAF. The gene discussed is BRAF; the disease is melanoma.